ArticleJournal of the American Heart Association2013

Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling.

Ioannis Karakikes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.